Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

COVID-19 5Neoplasms 2Hematologic Neoplasms 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Leukemia, Myeloid, Acute 1Leukemia, Lymphocytic, Chronic, B-Cell 1Hematopoietic and Lymphatic System Neoplasm 1Chronic Disease 1

Interventions

Interviews as Topic 12Specimen Handling 9Practice Guidelines as Topic 8Standard of Care 7Educational Status 7Methods 5Early Intervention, Educational 5Patient Navigation 4Health Promotion 3Acupressure 3Telemedicine 2Restraint, Physical 2Behavior Therapy 2Aromatherapy 2theanine 1ruxolitinib 1merphos 1lavender oil 1jojoba wax 1axatilimab 1X-Rays 1Tacrolimus 1Surveys and Questionnaires 1Stem Cell Transplantation 1Spiritual Therapies 1Spinal Puncture 1Resistance Training 1Psychotherapy 1Psilocybin 1Phantoms, Imaging 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Hematopoietic and Lymphatic System Neoplasm × BNT162 Vaccine × Clear all
NCT07390968 2026-02-09

Self-Amplifying mRNA COVID-19 Vaccine (LUNAR-COV19) Versus Comirnaty Vaccine in Adult Hematopoietic Cell Transplant Patients

Fred Hutchinson Cancer Center

Phase 2 Not yet recruiting
56 enrolled

Hematopoietic and Lymphatic System Neoplasm

Data powered by HemOnc (CC BY 4.0) Colophon âš¡